Recently, Galectin 3 has been implicated in the development of a number of diseases such as cancer, stroke, and inflammatory-driven pathological conditions (Dumic et al., 2006;, Henderson and Sethi, 2009; Rahimian et al., 2021). Here, LGALS3 is linked to cancer.